PATENT CLAIM ANALYSIS

Application Number: 16294971
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "497000"]

Abstract:
A method for temporarily relieving sinus congestion and pressure comprising administering to a human a dose of a multi-particle pulsatile oral dosage form with an immediate release form and a plurality of delayed release particles. The immediate release form contains about 10 mg phenylephrine hydrochloride. The delayed release form contains a core with coatings including a phenylephrine coating containing about 10 mg phenylephrine hydrochloride and a pH sensitive coating.

Claim (Index 10):
The method of  claim 1  wherein the pulsatile dosage form comprises a C max2 , an AUC 0-4 , and an AUC 4-8 , wherein the Cmax2, the AUC 04 , and the AUC 4-8  for the pulsatile dosage form meets or exceeds systemic exposures relative to two sequential doses of an immediate release phenylephrine taken four hours apart.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.67442
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15460459', '14857848', '15701669', '11756881', '14661639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659400149402644
- 35 USC 102 Novelty (BERT): 0.6017778157384753
- Combined Prediction Score: 0.7495237950200856
- Mean Citation Score: 376.671322
- Max Citation Score: 506.72052
- Similarity Product: 503.09420922032126

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test